Myriad Genetics Inc banner

Myriad Genetics Inc
XETRA:MYD

Watchlist Manager
Myriad Genetics Inc Logo
Myriad Genetics Inc
XETRA:MYD
Watchlist
Price: 26.72 EUR 1.98%
Market Cap: €2.1B

Intrinsic Value

MYD price has not been updated for more than 5 months. This may indicate that the stock has been delisted.

The intrinsic value for Myriad Genetics Inc (MYD) under the Base Case is 78.59 EUR. Compared with the current market price of 26.72 EUR, the stock appears Undervalued by 66%.

Based on two methods:

DCF suggests overvaluation, while multiples suggest undervaluation.

MYD Intrinsic Value
78.59 EUR
Undervaluation 66%
Intrinsic Value
Price €26.72
Worst Case
Base Case
Best Case
Get notified when the price drop
Track Buy Zone
20% below Intrinsic Value €62.87
Get notified when the price drops into your buy zone
Intrinsic Value €78.59
Margin of Safety 20% €62.87
Current Price €26.72
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about MYD?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is MYD valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Myriad Genetics Inc.

Explain Valuation
Alternatives to MYD

Wall St
Price Targets

Dividends

Shareholder Yield

Competitive Landscape

Ownership

MYGN Insider Trading
Buy and sell transactions by insiders

MYD News

What is the Intrinsic Value of one MYD stock?

The intrinsic value for Myriad Genetics Inc (MYD) under the Base Case is 78.59 EUR.

Is MYD stock undervalued or overvalued?

Compared with the current market price of 26.72 EUR, the stock appears Undervalued by 66%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett